EN DE
STOCK COMPARISON

BioHarvest Sciences Inc. Common Stock vs Nestle S.A.: Fair Value & Quality

Both stocks run through our valuation models. Here is how BioHarvest Sciences Inc. Common Stock (BHST) and Nestle S.A. (NESN) compare, as of Aug 30, 2026.

As of Aug 30, 2026, Fair Value Calculator sees Nestle S.A. as the less overvalued of the two: BioHarvest Sciences Inc. Common Stock trades at $1.84 versus a fair value of $0.31 (-83%), while Nestle S.A. trades at CHF 78.62 versus CHF 57.26 (-27%).
BioHarvest Sciences Inc. Common Stock
BHST · USD · Consumer Staples
-83%
upside to fair value
overvalued
Price$1.84
Fair Value$0.31
Quality35/100
Nestle S.A.
NESN.SW · CHF · Consumer Staples
-27%
upside to fair value
overvalued
PriceCHF 78.62
Fair ValueCHF 57.26
Quality69/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

BioHarvest Sciences Inc. Common StockNestle S.A.
Valuation
P/E (TTM)23.9×
2.12×P/S (TTM)2.97×
2.92×P/B8.12×
EV/EBITDA18.4×
PEG2.31×
Dividend yield3.9%
Dividend per shareCHF 3.10
Profitability
-33%Net margin10%
-22%Operating margin15%
-103%Return on equity27%
-10%Return on assets7%
Growth
8%Revenue growth (YoY)-2%
84.5%Avg. growth/yr (3Y)-1.9%
144.4%Avg. growth/yr (5Y)1.1%
Balance & size
0.10×Debt / equity1.34×
$74MMarket cap$267B
expensiveGrowth qualityweak

BioHarvest Sciences Inc. Common Stock leads: 6 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

BioHarvest Sciences Inc. Common Stockof which business quality 35 · market factors 5 Nestle S.A.of which business quality 64 · market factors 61
ProfitabilityMargins and returns on capital today
26
60
Quality GrowthAre margins and returns improving?
78
43
CashflowEarnings quality: real cash, not paper profit
3
67
Fin. StrengthBalance sheet, leverage, solvency risk
69
42
InvestmentDisciplined investing over empire-building
37
94
Low VolatilityCalm price path (market factor)
17
92
MomentumPrice trend over the last 3–12 months (market factor)
0
46
52W MomentumDistance to the 52-week high (market factor)
0
53
Net IssuanceBuybacks instead of dilution
0
94

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

BioHarvest Sciences Inc. Common Stock

Asset-Based$0.75

1 of 1 models see the stock below the current price.

Nestle S.A.

DCF ModelsCHF 47.70
Earnings-BasedCHF 33.53
Dividend DiscountCHF 34.87
MultiplesCHF 66.73
Asset-BasedCHF 8.55
Growth DCFCHF 45.56
Economic ProfitCHF 32.75
Growth EarningsCHF 55.79

23 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

BioHarvest Sciences Inc. Common Stock
Bear $0.20Fair Value $0.31Bull $0.39
$1.84 = current price (white tick)
Nestle S.A.
Bear CHF 35.23Fair Value CHF 57.26Bull CHF 81.98
CHF 78.62 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

BioHarvest Sciences Inc. Common Stock · Consumer Staples

Quality score35 · bottom 25%
Fair value upside-83% · bottom 25%

Nestle S.A. · Consumer Staples

Quality score69 · Top 25%
Fair value upside-27% · below median

Bottom line

As of Aug 30, 2026, Fair Value Calculator sees Nestle S.A. as the less overvalued of the two: BioHarvest Sciences Inc. Common Stock trades at $1.84 versus a fair value of $0.31 (-83%), while Nestle S.A. trades at CHF 78.62 versus CHF 57.26 (-27%).

Nestle S.A. has the higher quality score (69/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.